KalVista Pharmaceuticals, Inc. Earnings Per Share Diluted

• KalVista Pharmaceuticals, Inc. showed a decrease of -7.3% in Earnings Per Share Diluted from 2024 to 2025.
• This data is from KalVista Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on July 10, 2025.
• XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 6 years of available data (2020 to 2025), KalVista Pharmaceuticals, Inc.'s Earnings Per Share Diluted has declined by 125.0%.
• Historical annual values: Fiscal year 2025: $3.69 (loss) per share | Fiscal year 2024: $3.44 (loss) per share | Fiscal year 2023: $3.33 (loss) per share | Fiscal year 2022: $3.36 (loss) per share | Fiscal year 2021: $2.42 (loss) per share | Fiscal year 2020: $1.64 (loss) per share.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026